Woodcock: COVID Is Not The Time For Structural Changes At US FDA

 
• By Sarah Karlin-Smith
  
Janet Woodcock speaks at Alliance for a Stronger FDA
FDA Acting Commissioner Janet Woodcock speaks at the Alliance for a Stronger FDA on 14 April. • Source: Screenshot

More from US FDA

More from Agency Leadership